Immunosuppressive therapy in myelodysplastic syndrome

Cancer sa suso

Susunod

Auto-play

ARC TALKS Webinar: Physical Therapy for Amyloidosis Management

0 Mga view . 06/06/25 administrator

Daratumumab-based frontline therapy in AL amyloidosis: real-world Mayo Clinic experience

0 Mga view . 06/06/25 administrator

The main goals of therapy in AL amyloidosis

0 Mga view . 06/06/25 administrator

Anthony Brown & group therAPy - Trust In You (Official Video)

9 Mga view . 04/10/25 administrator

Indian patient visited China for CAR T-Cell therapy - Patient testimonial - Call +91 96 1588 1588

15 Mga view . 04/13/24 Sandeep Kumar

Organ Preserving Therapy of Advanced Rectal Cancer (OPRA Study)

5 Mga view . 10/15/23 administrator

Total Neoadjuvant Therapy in Rectal Cancer in the Community Setting | 2022 Evolution Conference

11 Mga view . 10/15/23 administrator

Is short-course radiation the best course of therapy in rectal cancer?

0 Mga view . 10/15/23 administrator

TRT Hormone Therapy | Pituitary Adenoma | Signs of low T

2 Mga view . 09/10/23 administrator

How does empty sella syndrome affect the pituitary gland?

3 Mga view . 09/10/23 administrator

Pituitary Adenoma Radiation Therapy

2 Mga view . 09/10/23 administrator

Polycystic Ovary Syndrome | PCOS | Nucleus Health

2 Mga view . 09/10/23 administrator

Polycystic Ovary Syndrome | PCOS | Nucleus Health

3 Mga view . 09/10/23 administrator

Syndrome Series: Gardner Syndrome

6 Mga view . 09/10/23 administrator

Syndrome Series: Gardner Syndrome

6 Mga view . 09/10/23 administrator

What is FAP Syndrome Disease?r ???PART 2

4 Mga view . 09/10/23 administrator

Metabolic Therapy Update - Stage 4 Ewing's Sarcoma

2 Mga view . 09/10/23 administrator

Ewing's U (Episode 10): Maintenance Therapy in Ewing Sarcoma with Dr. Bailey and Dr. Setty

3 Mga view . 09/10/23 administrator

STEAP1 targeting CAR-T therapy for solid tumors

0 Mga view . 09/10/23 administrator

STEAP1 targeting CAR-T therapy for solid tumors

3 Mga view . 09/10/23 administrator

Immunosuppressive therapy in myelodysplastic syndrome

12 Mga view • 07/04/23

I-embed

administrator

Mga subscriber

Dr Stahl speaks with ecancer at the 2017 ASH annual meeting about the use of immunosuppressive therapy in patients with the myelodysplastic syndromes.

He outlines biomarkers assessed in the hopes of finding predictive factors for patient response, noting that only SF3B1 mutations were validated, negatively affecting response to IST.

Dr Stahl also describes differences in overall survival for patients achieving an objective response.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Magpakita ng higit pa

0 Mga komento

Mga Komento sa Facebook

Pakitandaan na kung wala ka pang 18 taong gulang, hindi mo maa-access ang site na ito.

Susunod

Immunosuppressive therapy in myelodysplastic syndrome

Susunod

Wika